An update on autoimmune inner ear disease: A systematic review of pharmacotherapy

2020 ◽  
Vol 41 (1) ◽  
pp. 102310 ◽  
Author(s):  
David Strum ◽  
Sunny Kim ◽  
Timothy Shim ◽  
Ashkan Monfared
2020 ◽  
Vol 5 (6) ◽  
pp. 1217-1226
Author(s):  
Nathaniel K. Breslin ◽  
Varun V. Varadarajan ◽  
Eric S. Sobel ◽  
Rex S. Haberman

2015 ◽  
Vol 36 (10) ◽  
pp. 1585-1592 ◽  
Author(s):  
Jason A. Brant ◽  
Steven J. Eliades ◽  
Michael J. Ruckenstein

Author(s):  
Virginia Corazzi ◽  
Stavros Hatzopoulos ◽  
Chiara Bianchini ◽  
Magdalena B Skarżyńska ◽  
Stefano Pelucchi ◽  
...  

1993 ◽  
Vol 21 (4) ◽  
pp. 192-196 ◽  
Author(s):  
Aytac Saraçaydin ◽  
Sedat Katircioğlu ◽  
Sami Katircioğlu ◽  
M Can Karatay

A total of twelve patients with a relatively uncommon form of progressive sensorineural deafness (autoimmune innerear disease) were treated orally with 1 mg/kg azathioprine, once daily, and with 30 mg prednisolone, every other day, for 4 weeks. Statistically significant increases in the ability to hear pure tones or in discrimination on audiometry took place in 10/12 patients. This condition was initially described as ‘sensorineural hearing loss', but it is now clear that the term ‘autoimmune inner-ear disease’ is more appropriate since the vestibular compartment as well as the cochlear compartment is involved. This relatively uncommon disease is one of the few forms of sensorineural deafness that can be successfully treated.


JAMA ◽  
2003 ◽  
Vol 290 (14) ◽  
pp. 1875 ◽  
Author(s):  
Jeffrey P. Harris ◽  
Michael H. Weisman ◽  
Jennifer M. Derebery ◽  
Mark A. Espeland ◽  
Bruce J. Gantz ◽  
...  

2013 ◽  
Vol 12 (3) ◽  
pp. 396-400 ◽  
Author(s):  
A. Greco ◽  
A. Gallo ◽  
M. Fusconi ◽  
G. Magliulo ◽  
R. Turchetta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document